Tenor Capital Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Tenor Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Tenor Capital Management from 13F filings

Historical chart of Tenor Capital Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Tenor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Tenor Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $71M 55M 1.29
2025-12-31 $53M 40M 1.33
2025-09-30 $15M 11M 1.41

More positions owned by Tenor Capital Management

Lumentum Hldgs Note 0.500%12/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Unity Software Note 11/1 (Principal)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Shake Shack Note 3/0 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Akamai Technologies Note 0.375% 9/0 (Principal)
Biomarin Pharmaceutical Note 1.250% 5/1 (Principal)
Jbt Marel Corporation Note 0.250% 5/1 (Principal)
Neogenomics Note 0.250% 1/1 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Jazz Investments I Note 2.000% 6/1 (Principal)
Ugi Corp Note 5.000% 6/0 (Principal)
Akamai Technologies Note 1.125% 2/1 (Principal)

View all positions for Tenor Capital Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Tenor Capital Management
Point72 Asset Management
LMR Partners
Alberta Investment Management Corporation
Millennium Management
Citadel Advisors
Balyasny Asset Management
Lazard Asset Management
Absolute Investment Advisers
Linden Advisors
Calamos Advisors
State Street Corporation
Franklin Resources
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Advent Capital Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1